Literature DB >> 16110935

Developing a questionnaire to measure the psychosocial impact of an abnormal cervical smear result and its subsequent management: the TOMBOLA (Trial of Management of Borderline and Other Low-grade Abnormal Smears) trial.

N M Gray1, L Sharp, S C Cotton, M Avis, Z Philips, I Russell, L G Walker, D Whynes, J Little.   

Abstract

This paper describes the process of developing and testing a new questionnaire, Process Outcome Specific Measure (POSM), including an assessment of its content validity and reliability. The questionnaire was developed within the context of Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA) to assess the psychosocial impact of a low-grade abnormal cervical smear result and the subsequent management. A literature search, focus groups and thorough pre-testing involving experts and patients resulted in a short (15-item), easily completed and understood questionnaire. Questions address issues including cancer, health, fertility and sexual concerns. Repeatability was assessed in 110 TOMBOLA recruits using weighted k; all but one of the questions showed levels of reliability near to, or above, 0.5. Cronbach's standardised alpha was 0.73, indicating acceptable internal consistency. Each POSM item was correlated with the anxiety and depression sub-scales of the Hospital Anxiety Depression Scale (HADS). All except one of the questions correlated more highly with the total POSM score than with the HADS sub-scales thus indicating discriminant validity. The POSM will enable comparison of the alternative management policies for low-grade cervical smears in terms of the benefits (or otherwise) perceived by the women managed by these policies.

Entities:  

Mesh:

Year:  2005        PMID: 16110935     DOI: 10.1007/s11136-004-8146-5

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  17 in total

1.  EuroQol--a new facility for the measurement of health-related quality of life.

Authors: 
Journal:  Health Policy       Date:  1990-12       Impact factor: 2.980

2.  Conservative versus aggressive follow up of mildly abnormal Pap smears: testing for process utility.

Authors:  Stephen Birch; Joy Melnikow; Miriam Kuppermann
Journal:  Health Econ       Date:  2003-10       Impact factor: 3.046

3.  Anxieties in women undergoing colposcopy.

Authors:  T M Marteau; P Walker; J Giles; M Smail
Journal:  Br J Obstet Gynaecol       Date:  1990-09

4.  Psychosexual trauma of an abnormal cervical smear.

Authors:  T Posner; M Vessey
Journal:  Br J Obstet Gynaecol       Date:  1988-07

5.  PEAPS-Q: a questionnaire to measure the psychosocial effects of having an abnormal pap smear. Psychosocial Effects of Abnormal Pap Smears Questionnaire.

Authors:  A Bennetts; L Irwig; B Oldenburg; J M Simpson; P Mock; A Boyes; K Adams; E Weisberg; J Shelley
Journal:  J Clin Epidemiol       Date:  1995-10       Impact factor: 6.437

6.  Psychological burden of women with mild cervical intraepithelial neoplasia.

Authors:  H Zeisler; K Mayerhofer; E Joura; M Sator; C Kainz
Journal:  Oncol Rep       Date:  1997 Sep-Oct       Impact factor: 3.906

7.  The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life.

Authors:  M A Sprangers; A Cull; K Bjordal; M Groenvold; N K Aaronson
Journal:  Qual Life Res       Date:  1993-08       Impact factor: 4.147

8.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

9.  Adverse psychologic consequences of positive cytologic cervical screening.

Authors:  C Lerman; S M Miller; R Scarborough; P Hanjani; S Nolte; D Smith
Journal:  Am J Obstet Gynecol       Date:  1991-09       Impact factor: 8.661

10.  Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study.

Authors:  Esther Maissi; Theresa M Marteau; Matthew Hankins; Sue Moss; Rosa Legood; Alastair Gray
Journal:  BMJ       Date:  2004-05-29
View more
  11 in total

Review 1.  Health-related quality of life as measured by the EQ-5D in the prevention, screening and management of cervical disease: A systematic review.

Authors:  A Ó Céilleachair; J F O'Mahony; M O'Connor; J O'Leary; C Normand; C Martin; L Sharp
Journal:  Qual Life Res       Date:  2017-06-26       Impact factor: 4.147

2.  Developing a measure of health-related quality of life for women with cervical dysplasia resulting from human papillomavirus infection.

Authors:  D Rao; N Gela; E M Daley; R Kattezham; G Rodriguez; D Cella
Journal:  Int J STD AIDS       Date:  2010-10       Impact factor: 1.359

3.  Long-term psychosocial impact of alternative management policies in women with low-grade abnormal cervical cytology referred for colposcopy: a randomised controlled trial.

Authors:  L Sharp; S Cotton; N Gray; M Avis; I Russell; L Walker; N Waugh; D Whynes; C Woolley; A Thornton; L Smart; M Cruickshank; J Little
Journal:  Br J Cancer       Date:  2010-12-21       Impact factor: 7.640

4.  Human papillomavirus infection and anxiety: analyses in women with low-grade cervical cytological abnormalities unaware of their infection status.

Authors:  Candice Y Johnson; Linda Sharp; Seonaidh C Cotton; Cheryl A Harris; Nicola M Gray; Julian Little
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

5.  Psychological impact, support and information needs for women with an abnormal Pap smear: comparative results of a questionnaire in three European countries.

Authors:  Joseph Monsonego; Javier Cortes; Daniel Pereira da Silva; Anna Francisca Jorge; Patrick Klein
Journal:  BMC Womens Health       Date:  2011-05-25       Impact factor: 2.809

6.  Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors.

Authors:  N M Gray; L Sharp; S C Cotton; L F Masson; J Little; L G Walker; M Avis; Z Philips; I Russell; D Whynes; M Cruickshank; C M Woolley
Journal:  Br J Cancer       Date:  2006-05-08       Impact factor: 7.640

7.  Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology.

Authors:  Ingeborg Zehbe; Robert Jackson; Brianne Wood; Bruce Weaver; Nicholas Escott; Alberto Severini; Mel Krajden; Lisa Bishop; Kyla Morrisseau; Gina Ogilvie; Ann N Burchell; Julian Little
Journal:  BMJ Open       Date:  2016-10-08       Impact factor: 2.692

8.  Development and psychometric properties of the human papillomavirus-quality of life (HPV-QoL) questionnaire to assess the impact of HPV on women health-related-quality-of-life.

Authors:  Pluvio J Coronado; Carmen González-Granados; Mar Ramírez-Mena; Javier Calvo; María Fasero; Mónica Bellón; Javier F García-Santos; Javier Rejas-Gutiérrez
Journal:  Arch Gynecol Obstet       Date:  2022-05-13       Impact factor: 2.493

9.  Measuring the psychosocial burden in women with low-grade abnormal cervical cytology in the TOMBOLA trial: psychometric properties of the Process and Outcome Specific Measure (POSM).

Authors:  Kieran Rothnie; Seonaidh C Cotton; Shona Fielding; Nicola M Gray; Julian Little; Margaret E Cruickshank; Leslie G Walker; Mark Avis; Linda Sharp
Journal:  Health Qual Life Outcomes       Date:  2014       Impact factor: 3.186

10.  Psychosocial morbidity in women with abnormal cervical cytology managed by cytological surveillance or initial colposcopy: longitudinal analysis from the TOMBOLA randomised trial.

Authors:  S Fielding; K Rothnie; N M Gray; J Little; M E Cruickshank; K Neal; L G Walker; D Whynes; S C Cotton; L Sharp
Journal:  Psychooncology       Date:  2016-06-14       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.